Efficacy of Factor Xa Inhibitors Versus Placebo in Thromboprophylaxis for Cancer-Associated Thromboembolism: A Systematic Review and Meta-analysis
Background Cancer patients are at significantly increased risk of venous thromboembolism (VTE), a leading cause of morbidity and mortality in this population. While traditional anticoagulants like low-molecular-weight heparin (LMWH) and vitamin K antagonists (VKAs) are commonly used, their limitatio...
Збережено в:
| Автори: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
SAGE Publishing
2025-09-01
|
| Серія: | Clinical and Applied Thrombosis/Hemostasis |
| Онлайн доступ: | https://doi.org/10.1177/10760296251372947 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|